Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study. [electronic resource]
Producer: 20200508Description: 125 p. digitalISSN:- 1471-2369
- Adolescent
- Adult
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Atypical Hemolytic Uremic Syndrome -- complications
- Child
- Complement Inactivating Agents -- administration & dosage
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
- Humans
- International Cooperation
- Long Term Adverse Effects -- diagnosis
- Male
- Medication Therapy Management
- Outcome and Process Assessment, Health Care
- Thrombotic Microangiopathies -- diagnosis
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.